Last Price
16.76
Today's Change
-0.61 (3.51%)
Day's Change
16.41 - 17.46
Trading Volume
4,609,908
Market Cap
0
Shares Outstanding
0
Avg Volume
314,255
Avg Price (50 Days)
15.69
Avg Price (200 Days)
16.69
PE Ratio
-11.45
EPS
-1.46
Earnings Announcement
10-Nov-2020
Previous Close
17.37
Open
17.29
Day's Range
16.41 - 17.46
Year Range
11.77 - 26.0
Trading Volume
4,611,685
1 Day Change
0.00%
5 Day Change
0.00%
1 Month Change
0.00%
3 Month Change
0.00%
6 Month Change
0.00%
Ytd Change
0.00%
1 Year Change
0.00%
3 Year Change
0.00%
5 Year Change
0.00%
10 Year Change
0.00%
Max Change
0.00%
No result.
Sector: Healthcare - Healthcare
Industry: Technical & System Software
Description:
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.